Angiopoietin-1, angiopoietin-2 and Tie-2 receptor expression in human dermal wound repair and scarring

British Journal of Dermatology

Volumn 163, Issue 5, 2010, Pages 920-927

  Staton, C A ^a   Valluru, M ^a   Hoh, L ^a   Reed, M W R ^a   Brown, N J ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

Angiogenesis; Angiopoietin; Tie 2; VEGF; Wound healing

Indexed keywords

ANGIOPOIETIN 1; ANGIOPOIETIN 2; ANGIOPOIETIN RECEPTOR; VASCULOTROPIN;

ANGIOGENESIS; ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; FIBROBLAST; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MASTECTOMY; MICROVASCULATURE; MYOFIBROBLAST; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN EXPRESSION; PUNCH BIOPSY; SCAR FORMATION; SURGICAL WOUND; WOUND HEALING;

ANGIOPOIETIN-1; ANGIOPOIETIN-2; BIOPSY; CICATRIX; ENDOTHELIAL CELLS; FEMALE; FIBROBLASTS; HUMANS; IMMUNOHISTOCHEMISTRY; MYOFIBROBLASTS; NEOVASCULARIZATION, PHYSIOLOGIC; RECEPTOR, TIE-2; SKIN; VASCULAR ENDOTHELIAL GROWTH FACTOR A; WOUND HEALING;

EID: 78249257796     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2010.09940.x     Document Type: Article

References (27)

1. Li WW, Talcott KE, Zhai AW, et al. The role of therapeutic angiogenesis in tissue repair and regeneration. Adv Skin Wound Care 2005; 18: 491 -500.
2. Gillard JA, Reed MW, Buttle D, et al. Matrix metalloproteinase activity and immunohistochemical profile of matrix metalloproteinase-2 and -9 and tissue inhibitor of metalloproteinase-1 during human dermal wound healing. Wound Repair Regen 2004; 12: 295 -304.
3. Kumar I, Staton CA, Cross SS, et al. Angiogenesis, vascular endothelial growth factor and its receptors in human surgical wounds. Br J Surg 2009; 96: 1484 -91.
4. Hantash BM, Zhao L, Knowles JA, et al. Adult and fetal wound healing Front Biosci 2008; 13: 51 -61.
5. Brown NJ, Smyth EA, Cross SS, et al. Angiogenesis induction and regression in human surgical wounds. Wound Repair Regen 2002; 10: 245 -51.
6. Eklund L, Olsen BR,. Tie receptors and their angiopoietin ligands are context-dependent regulators of vascular remodeling. Exp Cell Res 2006; 312: 630 -41.
7. Witzenbichler B, Maisonpierre PC, Jones P, et al. Chemotactic properties of angiopoietin-1 and -2, ligands for the endothelial-specific receptor tyrosine kinase Tie2. J Biol Chem 1998; 273: 18514 -21.
8. Hayes AJ, Huang WQ, Mallah J, et al. Angiopoietin-1 and its receptor Tie-2 participate in the regulation of capillary-like tubule formation and survival of endothelial cells. Microvasc Res 1999; 58: 224 -37.
9. Kwak HJ, So JN, Lee SJ, et al. Angiopoietin-1 is an apoptosis survival factor for endothelial cells. FEBS Lett 1999; 448: 249 -53.
10. Suri C, Jones PF, Patan S, et al. Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis. Cell 1996; 87: 1171 -80.
11. Thurston G, Suri C, Smith K, et al. Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1. Science 1999; 286: 2511 -14.
12. Maisonpierre PC, Suri C, Jones PF, et al. Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science 1997; 277: 55 -60.
13. Holash J, Wiegand SJ, Yancopoulos GD,. New model of tumor angiogenesis: dynamic balance between vessel regression and growth mediated by angiopoietins and VEGF. Oncogene 1999; 18: 5356 -62.
14. Wen CY, Ito M, Chen LD, et al. Expression of Tie-2 and angiopoietin-1 and -2 in early phase of ulcer healing. J Gastroenterol 2003; 38: 431 -5.
15. Kim KE, Cho CH, Kim HZ, et al. In vivo actions of angiopoietins on quiescent and remodeling blood and lymphatic vessels in mouse airways and skin. Arterioscler Thromb Vasc Biol 2007; 27: 564 -70.
16. Gruss CJ, Satyamoorthy K, Berking C, et al. Stroma formation and angiogenesis by overexpression of growth factors, cytokines, and proteolytic enzymes in human skin grafted to SCID mice. J Invest Dermatol 2003; 120: 683 -92.
17. Bitto A, Minutoli L, Galeano MR, et al. Angiopoietin-1 gene transfer improves impaired wound healing in genetically diabetic mice without increasing VEGF expression. Clin Sci (Lond) 2008; 114: 707 -18.
18. Maruyama E, Sakamoto T, Azuma H, et al. Involvement of angiopoietins in cancer progression in association with cancer cell-fibroblast interaction. Anticancer Res 2005; 25: 171 -7.
19. Zhu WH, MacIntyre A, Nicosia RF,. Regulation of angiogenesis by vascular endothelial growth factor and angiopoietin-1 in the rat aorta model: distinct temporal patterns of intracellular signaling correlate with induction of angiogenic sprouting. Am J Pathol 2002; 161: 823 -30.
20. Chae JK, Kim I, Lim ST, et al. Coadministration of angiopoietin-1 and vascular endothelial growth factor enhances collateral vascularization. Arterioscler Thromb Vasc Biol 2000; 20: 2573 -8.
21. Fiedler U, Scharpfenecker M, Koidl S, et al. The Tie-2 ligand angiopoietin-2 is stored in and rapidly released upon stimulation from endothelial cell Weibel-Palade bodies. Blood 2004; 103: 4150 -6.
22. Kampfer H, Pfeilschifter J, Frank S,. Expressional regulation of angiopoietin-1 and -2 and the tie-1 and -2 receptor tyrosine kinases during cutaneous wound healing: a comparative study of normal and impaired repair. Lab Invest 2001; 81: 361 -73.
23. Drinkwater SL, Burnand KG, Ding R, et al. Increased but ineffectual angiogenic drive in nonhealing venous leg ulcers. J Vasc Surg 2003; 38: 1106 -12.
24. Wong AL, Haroon ZA, Werner S, et al. Tie2 expression and phosphorylation in angiogenic and quiescent adult tissues Circ Res 1997; 81: 567 -74.
25. Lewis CE, De Palma M, Naldini L,. Tie2-expressing monocytes and tumor angiogenesis: regulation by hypoxia and angiopoietin-2. Cancer Res 2007; 67: 8429 -32.
26. Uchida T, Nakashima M, Hirota Y, et al. Immunohistochemical localisation of protein tyrosine kinase receptors Tie-1 and Tie-2 in synovial tissue of rheumatoid arthritis: correlation with angiogenesis and synovial proliferation. Ann Rheum Dis 2000; 59: 607 -14.
27. Martin V, Liu D, Fueyo J, et al. Tie2: a journey from normal angiogenesis to cancer and beyond. Histol Histopathol 2008; 23: 773 -80.